Evidence map›Paper›PMID 37104018›Full record

ReviewMethods and protocols2023

Established and Emerging Methods for Protecting Linear DNA in Cell-Free Expression Systems.

Trevor J Fochtman, Javin P Oza

Abstract readReview
In one paragraph

Review in Methods and protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Trevor J FochtmanDepartment of Chemistry & Biochemistry, California Polytechnic State University, San Luis Obispo, CA 93407, USA.
Javin P OzaDepartment of Chemistry & Biochemistry, California Polytechnic State University, San Luis Obispo, CA 93407, USA.ORCID 0000-0002-2902-6939

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-free protein synthesis (CFPS) is a method utilized for producing proteins without the limits of cell viability. The plug-and-play utility of CFPS is a key advantage over traditional plasmid-based expression systems and is foundational to the potential of this biotechnology. A key limitation of CFPS is the varying stability of DNA types, limiting the effectiveness of cell-free protein synthesis reactions. Researchers generally rely on plasmid DNA for its ability to support robust protein expression

Indexed as

cell-free protein synthesisChiDNA modificationsexonucleaseGamSKuLETslinear expression templatesnuclease inhibitionrecBCDTus-Ter

Identifiers

PMID37104018
PMCPMC10146267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.